Facilitated By

San Antonio Medical Foundation

Development of small molecule therapeutics against SARS-CoV-2

Texas Biomedical Research Institute


As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Shtanko, Olena
Funded by
Emergence Venture Partners, LLC
Research Start Date

The goal is to have immediate impact by identifying prophylactic/therapeutic interventions using micronutrients as effective, low-cost, low-risk countermeasures to reduce viral damage to human airway cells and mitigate virus spread during this pandemic. The impact of our focus on ?epithelial defense? will provide an immediate means to fortify airway epithelial barrier function early during SARS-CoV-2 illness, which will reduce lung water accumulation and dyspnea in infected patients.

Collaborative Project
Drug Discovery
Infectious Disease